CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd

BSE 533573 APLLTD INE901L01018
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

43 filings · 19 material · busiest 2026-08-04

What it files

Press Release9 Newspaper Publication7 Analyst / Investor Meet5 AGM / EGM3 General3 KMP2 Credit Rating2 Concall Transcript1

Filings

43 in the window

  1. 25 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached.

    Company Update / Newspaper Publication View filing →

  2. 20 August 2026

    KMP

    Appointment of Company Secretary and Compliance Officer

    Intimation regarding Appointment of Company Secretary of the Company.

    Company Update / Appointment of Company Secretary / Compliance Officer View filing →

  3. 11 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached.

    Company Update / Newspaper Publication View filing →

  4. 10 August 2026

    Concall Transcript

    Earnings Call Transcript

    Please find attached herewith the Transcript of Post Result Conference Call held on 4th August, 2026.

    Company Update / Earnings Call Transcript View filing →

  5. 10 August 2026

    KMP

    Resignation of Company Secretary / Compliance Officer

    Please find attached.

    Company Update / Resignation of Company Secretary / Compliance Officer View filing →

  6. 6 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August, 2026.

    AGM/EGM / AGM View filing →

  7. 5 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached herewith the Newspaper Advertisement.

    Company Update / Newspaper Publication View filing →

  8. 5 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Please find attached Proceedings of AGM held on 5th August, 2026.

    AGM/EGM / AGM View filing →

  9. 4 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Please find enclosed herewith Outcome of Board Meeting.

    Board Meeting / Outcome of Board Meeting View filing →

  10. 4 August 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Please find attached Unaudited Financial Results for the Quarter ended 30th June, 2026.

    Result / Financial Results View filing →

  11. 4 August 2026

    Investor Presentation

    Investor Presentation

    Please find attached Investor Presentation.

    Company Update / Investor Presentation View filing →

  12. 4 August 2026

    Press Release

    Press Release / Media Release

    Please find attached Press Release on Unaudited Financial Results for the quarter ended 30th June, 2026.

    Company Update / Press Release / Media Release View filing →

  13. 4 August 2026

    Press Release

    Press Release / Media Release (Revised)

    Please find attached Revised Press Release on Unaudited Financial Results for the quarter ended 30th June, 2026.

    Company Update / Press Release / Media Release (Revised) View filing →

  14. 4 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Please find attached audio recording of investor call.

    Company Update / Analyst / Investor Meet View filing →

  15. 28 July 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited receives USFDA Final approval for Prucalopride Tablets, 1 mg and 2 mg.

    Company Update / Press Release / Media Release View filing →

  16. 27 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find attached herewith Intimation for Investors Call Scheduled to be held on 4th August, 2026.

    Company Update / Analyst / Investor Meet View filing →

  17. 24 July 2026

    Board Meeting

    Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter Ended 30Th June, 2026.

    Alembic Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

  18. 13 July 2026

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Please find enclosed.

    Company Update / General View filing →

  19. 10 July 2026

    AGM / EGM

    Submission Of Notice Of The 16Th Annual General Meeting Of The Company.

    Please find enclosed herewith a copy of the Notice of the 16th Annual General Meeting of the Company scheduled to be held on Wednesday, 5th August, 2026 at 4:00 p.m. IST.

    AGM/EGM / AGM View filing →

  20. 10 July 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Please find enclosed herewith a copy of Annual Report of the Company for the Financial Year ended 31st March, 2026.

    Others / Reg. 34 (1) Annual Report View filing →

  21. 10 July 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Please find enclosed herewith a copy of the Business Responsibility and Sustainability Report of the Company including Reasonable Assurance Report for the Financial Year ended 31st March, 2026.

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  22. 10 July 2026

    Record Date

    Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2026.

    Please find enclosed herewith the intimation of Record Date for payment of Dividend on Equity Shares for the Financial Year ended 31st March, 2026.

    Corp. Action / Record Date View filing →

  23. 10 July 2026

    General

    Specimen Copy Of The Letter Sent To The Shareholders Under Regulation 36(1)(B) Of SEBI LODR

    Please find enclosed.

    Company Update / General View filing →

  24. 8 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find enclosed Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 30th June, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  25. 7 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed.

    Company Update / Newspaper Publication View filing →

  26. 1 July 2026

    Credit Rating

    Credit Rating

    Please find enclosed herewith the Intimation of Re-affirmation of Credit Rating.

    Company Update / Credit Rating View filing →

  27. 26 June 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension, 6mg/mL.

    Company Update / Press Release / Media Release View filing →

  28. 26 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed.

    Company Update / Newspaper Publication View filing →

  29. 26 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  30. 26 June 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%.

    Company Update / Press Release / Media Release View filing →

  31. 19 June 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited received USFDA Tentative Approval for Binimetinib Tablets, 45 mg.

    Company Update / Press Release / Media Release View filing →

  32. 19 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find enclosed herewith Intimation of One on One Meet.

    Company Update / Analyst / Investor Meet View filing →

  33. 19 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find enclosed herewith Intimation of One on One Meet.

    Company Update / Analyst / Investor Meet View filing →

  34. 19 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find enclosed herewith Intimation of One of One Meet.

    Company Update / Analyst / Investor Meet View filing →

  35. 18 June 2026

    Change in Directorate

    Change in Directorate

    Appointment of Mr. Sujit Bhayani as Non-Executive Independent Director of the Company w.e.f. 18th June, 2026.

    Company Update / Change in Directorate View filing →

  36. 12 June 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.

    Company Update / Press Release / Media Release View filing →

  37. 11 June 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg.

    Company Update / Press Release / Media Release View filing →

  38. 11 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed.

    Company Update / Newspaper Publication View filing →

  39. 11 June 2026

    Credit Rating

    Credit Rating

    Please find enclosed herewith the Intimation regarding re-affirmation of credit rating on Commercial Paper

    Company Update / Credit Rating View filing →

  40. 9 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed.

    Company Update / Newspaper Publication View filing →

  41. 5 June 2026

    Press Release

    Press Release / Media Release

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Haloperidol Tablets, USP.

    Company Update / Press Release / Media Release View filing →

  42. 5 June 2026

    General

    Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    Please find enclosed herewith specimen copy of the Reminder Letter sent to the shareholders of the Company holding shares in physical form for updating KYC details.

    Company Update / General View filing →

  43. 3 June 2026

    Change in Management

    Change in Management

    Please find enclosed.

    Company Update / Change in Management View filing →